Considering the opposing regulation of CCDC26 and IGF-1R in GIST cells treated with imatinib, it is possible that CCDC26 could increase the sensitivity of GIST cells to imatinib. The gene discussed is IGF1R; the disease is gastrointestinal stromal tumor.